Merck KGaA
MKKGY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $60,103,674 | $61,234,287 | $78,324,935 | $99,600,525 |
| - Cash | $2,149,000 | $1,982,000 | $1,398,000 | $1,511,000 |
| + Debt | $10,271,000 | $9,864,000 | $10,398,000 | $10,766,000 |
| Enterprise Value | $68,225,674 | $69,116,287 | $87,324,935 | $108,855,525 |
| Revenue | $21,156,000 | $20,993,000 | $22,232,000 | $19,687,000 |
| % Growth | 0.8% | -5.6% | 12.9% | – |
| Gross Profit | $12,485,000 | $12,393,000 | $13,705,000 | $12,336,000 |
| % Margin | 59% | 59% | 61.6% | 62.7% |
| EBITDA | $5,962,000 | $5,685,000 | $6,279,000 | $5,880,000 |
| % Margin | 28.2% | 27.1% | 28.2% | 29.9% |
| Net Income | $2,777,000 | $2,824,000 | $3,326,000 | $3,055,000 |
| % Margin | 13.1% | 13.5% | 15% | 15.5% |
| EPS Diluted | 1.28 | 1.3 | 1.53 | 1.41 |
| % Growth | -1.5% | -15% | 8.5% | – |
| Operating Cash Flow | $4,586,000 | $3,784,000 | $4,259,000 | $4,616,000 |
| Capital Expenditures | -$2,184,000 | -$2,023,000 | -$1,806,000 | -$1,421,000 |
| Free Cash Flow | $2,402,000 | $1,761,000 | $2,453,000 | $3,195,000 |